Adient Analyst Price Targets - Benzinga

Adient PLC

ADNTNYSE

Trade with Public

Trade with Public

$17.57

-0.47-2.61%

最終更新: Oct 14, 3:59 PM

$17.61

-0.43-2.38%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Adient Analyst Price Targets - Benzinga

Adient Analyst Price Targets

Wall Street analyst price targets and consensus rating for Adient (ADNT).

Price Target Range — 13 Quarters

Analyst Consensus — 9 Analysts

7Buy

1Hold

1Sell

Consensus RatingBuy# Analysts9Avg. Consensus PT$25Upside to Avg. PT+43.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 9, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$25→$22
Oct 7, 2026	UBS	Joseph Spak	PT Cut	Buy	$29→$23
Sep 15, 2026	JP Morgan	Rajat Gupta	Upgrade	Neutral→Overweight	$28→$25
Aug 18, 2026	Morgan Stanley	Andrew Percoco	PT Cut	Equal-Weight	$22→$21
Aug 11, 2026	Citigroup	Michael Ward	PT Cut	Buy	$33→$29
Aug 10, 2026	JP Morgan	Rajat Gupta	PT Raise	Neutral	$26→$28
Aug 10, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$29→$25
Aug 6, 2026	UBS	Joseph Spak	PT Cut	Buy	$34→$29
Jul 20, 2026	Stifel	Nathan Janes	PT Cut	Buy	$28→$26
Jul 9, 2026	UBS	Joseph Spak	PT Raise	Buy	$33→$34
Jul 6, 2026	Deutsche Bank	Edison Yu	PT Cut	Buy	$31→$29
Jun 25, 2026	Wells Fargo	Colin Langan	PT Raise	Overweight	$28→$32
May 11, 2026	Barclays	Dan Levy	PT Raise	Equal-Weight	$26→$29
May 7, 2026	UBS	Joseph Spak	PT Raise	Buy	$32→$33
Apr 23, 2026	JP Morgan	Ryan Brinkman	PT Cut	Neutral	$28→$26
Apr 15, 2026	Citigroup	Michael Ward	Upgrade	Neutral→Buy	$30→$33
Apr 14, 2026	Stifel	Nathan Janes	PT Cut	Buy	$30→$26
Mar 31, 2026	Wells Fargo	Colin Langan	PT Cut	Overweight	$29→$28
Mar 30, 2026	Barclays	Dan Levy	PT Cut	Equal-Weight	$27→$26
Feb 9, 2026	Citigroup	Michael Ward	PT Raise	Neutral	$23→$30

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Equal-Weight on Adient, Lowers Price Target to $22

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $25 to $22.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Adient, Lowers Price Target to $23

UBS analyst Joseph Spak maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $23.

Benzinga Newsdesk

PRO
JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25

JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Adient, Lowers Price Target to $21

Morgan Stanley analyst Andrew Percoco maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $22 to $21.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Adient, Lowers Price Target to $29

Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $33 to $29.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Adient, Raises Price Target to $28

JP Morgan analyst Rajat Gupta maintains Adient (NYSE:ADNT) with a Neutral and raises the price target from $26 to $28.

Benzinga Newsdesk